Use of Cardiotrophin-1 as a Biomarker of Cellular Senescence in Estrogen Receptor Positive Breast Cancer Cells
Özdemir A., Tayyar T., Ark M., Şimay Demir Y. D.
Patent, CHAPTER A Human Needs, The Invention Registration Number: 2024/006099 , Standard Registration, 2024, 2026, Registered / Approved
- Intellectual Property: Patent
- Country/Organization of Application: Turkey
- Status of The Invention: Pending / Applied
- Recourse Date: 5/17/2024
- Country/Organization of Application: Turkey
- Status of The Invention: Registered / Approved
- Recourse Date: 5/17/2024
- Registration Date: 1/21/2026